Search Results 481-490 of 16648 for primary sclerosing cholangitis

1. Alzheimer's disease - Doctors and departments - Mayo Clinic

   Understand more about this brain disorder that's the most common cause of dementia. Also learn about new tests and medicines on the market.

2. A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) - Mayo Clinic

   * Have a concomitant diagnosis of primary biliary sclerosis, primary sclerosing cholangitis, IgG 4 related cholangitis, drug related AIH (at Screening) or a ...

3. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States - Mayo Clinic

   ... primary sclerosing cholangitis and primary biliary cholangitis, cardiac cirrhosis or Fontan-associated liver disease, alpha-1-anti-trypsin, Wilson's disease ...

4. Hepatitis C - Care at Mayo Clinic

   Many people with this infection don't know they have it. Find out about symptoms and treatment for this liver disease that can be dangerous.

5. A Study to Evaluate Effectiveness and Safety of TD-1473 in Ulcerative Colitis - Mayo Clinic

   Participation eligibility · Has symptoms suggestive of fulminant colitis, megacolon or intestinal perforation. · Has primary sclerosing cholangitis (PSC). · Likely ...

6. A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) - Mayo Clinic

   * Participants with a chronic liver diseases other than NASH cirrhosis, such as primary biliary cholangitis, primary sclerosing cholangitis, Hepatitis B ...

7. A Study to Assess the Efficacy, Safety, and Tolerability of Oral LPCN 1148 in Male Subjects With Cirrhosis of the Liver and Sarcopenia - Mayo Clinic

   Steatohepatitis (NASH), Primary Biliary Cholangitis (PBC), or Primary Sclerosing Cholangitis (PSC) 3. Evidence of sarcopenia with appropriate cutoff ...

8. Publications - Eunhee S. Yi, M.D. - Mayo Clinic

   ... sclerosing pneumocytoma. Am J Clin Pathol. 2023 Dec 1; 160 (6): ... Histopathologic findings in lung biopsies from patients with primary biliary cholangitis.

9. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

   Primary biliary cirrhosis; Primary sclerosing cholangitis; Wilson's disease; Alpha-1-antitrypsin deficiency; Hemochromatosis or iron overload; Drug-induced ...

10. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    ... primary treatment objective. "Administering therapies directed at mucosal healing that may favorably modify the natural history of IBD when used in a treat ...